Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
SELVAS HEALTHCARE, INC. SELVAS Healthcare, Inc. Stock price
Equities
A208370
KR7208370007
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 7,530.00 KRW | +0.40% | +4.44% | +260.29% | |
| Sales 2023 * | 32 0 | Sales 2024 * | - | Capitalization | 193 B 149 M |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 6,00x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
| P/E ratio 2023 * | - | P/E ratio 2024 * | Employees | 110 | |
| Yield 2023 * | - | Yield 2024 * |
-
| Free-Float | 47.54% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.40% | ||
| 1 week | +4.44% | ||
| Current month | +7.57% | ||
| 1 month | +5.46% | ||
| 3 months | -10.14% | ||
| 6 months | +18.03% | ||
| Current year | +260.29% |
1 week
7 120.00
7 790.00
1 month
6 160.008 260.00
Current year
1 945.0014 090.00
1 year
1 920.0014 090.00
3 years
1 730.0014 090.00
5 years
1 395.0014 090.00
10 years
1 395.0014 090.00
| Managers | Title | Age | Since |
|---|---|---|---|
Byeong-Tak Yoo
CEO | Chief Executive Officer | 49 | 2016 |
Young-Gul Kim
BRD | Director/Board Member | 55 | 2017 |
Sang-Heon Lee
AUD | Comptroller/Controller/Auditor | 50 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Min-Cheol Kwak
BRD | Director/Board Member | 48 | 2016 |
Byeong-Tak Yoo
CEO | Chief Executive Officer | 49 | 2016 |
Jae-Ho Kim
BRD | Director/Board Member | 48 | 2019 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-11-30 | 7,530.00 | +0.40% | 606,703 |
| 23-11-29 | 7,500.00 | -1.19% | 1,684,761 |
| 23-11-28 | 7,590.00 | +3.41% | 1,213,526 |
| 23-11-27 | 7,340.00 | +0.82% | 703,653 |
| 23-11-24 | 7,280.00 | +1.53% | 520,985 |
End-of-day quote Korea Stock Exchange, November 29, 2023
More quotes
Selvas Healthcare Inc is a Korea-based company principally engaged in the manufacture and sale of digital healthcare products. The Company is engaged in the manufacture and sale of medical devices and other products. In addition, the Company is engaged in the development and sale of healthcare software.
Calendar
2024-03-31
- Q4 2023 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +260.29% | 149 M $ | |
| -9.97% | 190 B $ | |
| -15.87% | 164 B $ | |
| +17.14% | 109 B $ | |
| +20.79% | 81 219 M $ | |
| +13.29% | 64 147 M $ | |
| -7.94% | 48 559 M $ | |
| -9.25% | 40 896 M $ | |
| -14.60% | 37 272 M $ | |
| +17.27% | 30 825 M $ |
